These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27105663)

  • 1. Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum.
    Serrano-Pozo A; Qian J; Muzikansky A; Monsell SE; Montine TJ; Frosch MP; Betensky RA; Hyman BT
    J Neuropathol Exp Neurol; 2016 Jun; 75(6):516-26. PubMed ID: 27105663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease.
    Nelson PT; Abner EL; Schmitt FA; Kryscio RJ; Jicha GA; Santacruz K; Smith CD; Patel E; Markesbery WR
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):774-84. PubMed ID: 19535994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Correlations between Postmortem Brain Pathologies and Cognitive Dysfunction in Aging and Alzheimer's Disease.
    Qiu WY; Yang Q; Zhang W; Wang N; Zhang D; Huang Y; Ma C
    Curr Alzheimer Res; 2018 Mar; 15(5):462-473. PubMed ID: 29110614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Spectrum of Alzheimer-Type Pathology in Cognitively Normal Individuals.
    Walker JM; Dehkordi SK; Schaffert J; Goette W; White Iii CL; Richardson TE; Zare H
    J Alzheimers Dis; 2023; 91(2):683-695. PubMed ID: 36502330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging.
    Beach TG; Sue LI; Walker DG; Sabbagh MN; Serrano G; Dugger BN; Mariner M; Yantos K; Henry-Watson J; Chiarolanza G; Hidalgo JA; Souders L
    J Alzheimers Dis; 2012; 28(4):869-76. PubMed ID: 22112552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD.
    Sabbagh MN; Cooper K; DeLange J; Stoehr JD; Thind K; Lahti T; Reisberg B; Sue L; Vedders L; Fleming SR; Beach TG
    Curr Alzheimer Res; 2010 Jun; 7(4):280-6. PubMed ID: 19715548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resilience and resistance to the accumulation of amyloid plaques and neurofibrillary tangles in centenarians: An age-continuous perspective.
    Zhang M; Ganz AB; Rohde S; Rozemuller AJM; Bank NB; Reinders MJT; Scheltens P; Hulsman M; Hoozemans JJM; Holstege H
    Alzheimers Dement; 2023 Jul; 19(7):2831-2841. PubMed ID: 36583547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria.
    Nagy Z; Esiri MM; Jobst KA; Morris JH; King EM; McDonald B; Litchfield S; Smith A; Barnetson L; Smith AD
    Dementia; 1995; 6(1):21-31. PubMed ID: 7728216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive composite score association with Alzheimer's disease plaque and tangle pathology.
    Malek-Ahmadi M; Chen K; Perez SE; He A; Mufson EJ
    Alzheimers Res Ther; 2018 Sep; 10(1):90. PubMed ID: 30205840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
    Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
    Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease.
    Lowe VJ; Lundt ES; Albertson SM; Przybelski SA; Senjem ML; Parisi JE; Kantarci K; Boeve B; Jones DT; Knopman D; Jack CR; Dickson DW; Petersen RC; Murray ME
    Alzheimers Dement; 2019 Jul; 15(7):927-939. PubMed ID: 31175025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
    Attems J; Jellinger KA
    Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology of clinical and preclinical Alzheimer's disease.
    Thal DR; von Arnim C; Griffin WS; Yamaguchi H; Mrak RE; Attems J; Upadhaya AR
    Eur Arch Psychiatry Clin Neurosci; 2013 Nov; 263 Suppl 2():S137-45. PubMed ID: 24077890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.
    Murray ME; Lowe VJ; Graff-Radford NR; Liesinger AM; Cannon A; Przybelski SA; Rawal B; Parisi JE; Petersen RC; Kantarci K; Ross OA; Duara R; Knopman DS; Jack CR; Dickson DW
    Brain; 2015 May; 138(Pt 5):1370-81. PubMed ID: 25805643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histopathological staging of tau, but not amyloid, corresponds to antemortem cognitive status, dementia stage, functional abilities and neuropsychiatric symptoms.
    Malpas CB; Sharmin S; Kalincik T
    Int J Neurosci; 2021 Aug; 131(8):800-809. PubMed ID: 32303140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation.
    Yilmazer-Hanke DM; Hanke J
    Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction?
    Abner EL; Kryscio RJ; Schmitt FA; Santacruz KS; Jicha GA; Lin Y; Neltner JM; Smith CD; Van Eldik LJ; Nelson PT
    J Alzheimers Dis; 2011; 25(3):445-53. PubMed ID: 21471646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathology of Alzheimer's disease: a critical update.
    Jellinger KA; Bancher C
    J Neural Transm Suppl; 1998; 54():77-95. PubMed ID: 9850917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing between neurodegenerative disease and disease-free aging: correlating neuropsychological evaluations and neuropathological studies in centenarians.
    Silver MH; Newell K; Brady C; Hedley-White ET; Perls TT
    Psychosom Med; 2002; 64(3):493-501. PubMed ID: 12021423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.